COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data

Abstract

In a nationwide cohort of 19.5 million individuals, new diagnoses of AF decreased substantially following the onset of the COVID-19 pandemic. Our findings evidence pandemic disruptions in access to care for AF, which are concerning because delayed diagnosis interferes with timely treatment to prevent complications.